BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 1,771.00
-23.00 (-1.28%)
At close: Aug 12, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 8.73 billion as of August 12, 2026. Its market cap has decreased by -66.53% in one year.
Market Cap
8.73B
Enterprise Value
13.14B
Revenue
23.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,771.00
ChartMarket Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 8.73B, a decrease of -93.81%. That is a compound annual growth rate of -55.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 8.73B | -62.07% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 211.93B |
| DreamCIS | 83.40B |
| P&K Skin Research Center | 52.33B |
| Kolmar BioTech | 39.30B |
| HLB bioStep | 35.80B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 23.52B |
| C&R Research | 21.79B |